Lung cancer is emerging as a public health crisis. Yet, there is limited information on the lifetime risk of developing and dying from lung cancer at global, regional, and national levels. To bridge this gap, researchers from China estimated the lifetime risk of lung cancer across 185 countries in 2022. Their findings reveal the diverse impact of lung cancer across countries, sexes, and age groups, highlighting the need for more targeted interventions.

Researchers have developed a three-step plan to support those burdened by the intense fear of cancer returning. This plan offers a consistent, streamlined approach to managing recurrence anxiety, empowering patients to regain confidence and move forward with their lives.

In a paper published in MedComm, an international team of scientists combined principles of bioengineering, biocoupling, and micro–nanotechnology to introduce a subclassification system based on these design principles and provide an in-depth discussion on the current status of clinical transformation of micro- and nanostructured systems inspired by plants, microorganisms, and animals, as well as the encountered challenges during this process for the first time. This work will establish a robust theoretical framework and serve as a valuable reference to facilitate advancements in research and clinical application within this field.

Today, women with oestrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumours have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumour characteristics who had not yet gone through the menopause. The results are reported in the Journal of the National Cancer Institute (JNCI).

Scientists at St. Jude Children’s Research Hospital identified a panel of 27 proteins that could accurately predict treatment-related cardiomyopathy risk among childhood cancer survivors.